LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration

Genes and Development

Volumn 21, Issue 14, 2007, Pages 1767-1778

  Shun, Ming Chieh ^a   Raghavendra, Nidhanapati K ^a   Vandegraaff, Nick ^a,d   Daigle, Janet E ^a   Hughes, Siobhan ^b   Kellam, Paul ^c   Cherepanov, Peter ^b   Engelman, Alan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Avexa Ltd   (Australia)

Author keywords

AIDS; HIV 1; Integrase; Integration; LEDGF p75; Transcription

Indexed keywords

LENS EPITHELIUM DERIVED GROWTH FACTOR; PROTEIN P75;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA SEQUENCE; DNA STRAND; DNA TRANSFER; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPORTER GENE; VIRUS DNA CELL DNA INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CONSENSUS SEQUENCE; CPG ISLANDS; DNA; GENE DELETION; HIV-1; HUMANS; INTEGRASES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA VIRUS, MURINE; MICE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; RETROVIRIDAE;

EID: 34447513231     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1565107     Document Type: Article

References (60)

1. Ariumi, Y., Turelli, P., Masutani, M., and Trono, D. 2005. DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration. J. Virol. 79: 2973-2978.
2. Berry, C., Hannenhalli, S., Leipzig, J., and Bushman, F.D. 2006. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol. 2: e157. doi: doi:10.1371/journal.pcbi.0020157.
3. Brown, P.O., Bowerman, B., Varmus, H.E., and Bishop, J.M. 1987. Correct integration of retroviral DNA in vitro. Cell 49: 347-356.
4. Bushman, F., Lewinski, M., Ciuffi, A., Barr, S., Leipzig, J., Hannenhalli, S., and Hoffmann, C. 2005. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3: 848-858.
5. Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., and Debyser, Z. 2005. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem. 280: 17841-17847.
6. Carteau, S., Hoffmann, C., and Bushman, F. 1998. Chromosome structure and human immunodeficiency virus type 1 cDNA integration: Centromeric alphoid repeats are a disfavored target. J. Virol. 72: 4005-4014.
7. Cherepanov, P. 2007. LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res. 35: 113-124.
8. Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., and Debyser, Z. 2003. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 278: 372-381.
9. Cherepanov, P., Devroe, E., Silver, P.A., and Engelman, A. 2004. Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase. J. Biol. Chem. 279: 48883-48892.
10. Cherepanov, P., Ambrosio, A.L., Rahman, S., Ellenberger, T., and Engelman, A. 2005a. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl. Acad. Sci. 102: 17308-17313.
11. Cherepanov, P., Sun, Z.-Y., Rahman, S., Maertens, G., Wagner, G., and Engelman, A. 2005b. Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat. Struct. Mol. Biol. 12: 526-532.
12. Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J.R., and Bushman, F. 2005. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 11: 1287-1289.
13. Craigie, R., Fujiwara, T., and Bushman, F. 1990. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62: 829-837.
14. Crise, B., Li, Y., Yuan, C., Morcock, D.R., Whitby, D., Munroe, D.J., Arthur, L.O., and Wu, X. 2005. Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol. 79: 12199-12204.
15. Deininger, P.L. and Batzer, M.A. 1999. Alu repeats and human disease. Mol. Genet. Metab. 67: 183-193.
16. Emiliani, S., Mousnier, A., Busschots, K., Maroun, M., Van Maele, B., Tempe, D., Vandekerckhove, L., Moisant, F., Ben-Slama, L., Witvrouw, M., et al. 2005. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J. Biol. Chem. 280: 25517-25523.
17. Engelman, A. 2007. Isolation and analysis of HIV-1 preintegration complexes. In HIV protocols, 2nd edition (eds. V.R. Prasad and G.V. Kalpana) (in press). Humana Press, Totowa, NJ.
18. Engelman, A., Mizuuchi, K., and Craigie, R. 1991. HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell 67: 1211-1221.
19. Ge, H., Si, Y., and Roeder, R.G. 1998. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J. 17: 6723-6729.
20. Goff, S.P. 2007. Host factors exploited by retroviruses. Nat. Rev. Microbiol. 5: 253-263.
21. Hayashi, S., Lewis, P., Pevny, L., and McMahon, A.P. 2002. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech. Dev. 119 (Suppl. 1): S97-S101. doi: 10.1016/S0925-4773(03)00099-6.
22. Holman, A.G. and Coffin, J.M. 2005. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc. Natl. Acad. Sci. 102: 6103-6107.
23. Katz, R.A., Merkel, G., Kulkosky, J., Leis, J., and Skalka, A.M. 1990. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63: 87-95.
24. Kim, J., Daniel, J., Espejo, A., Lake, A., Krishna, M., Xia, L., Zhang, Y., and Bedford, M.T. 2006. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 7: 397-403.
25. Lesage, P. and Todeschini, A.L. 2005. Happy together: The life and times of Ty retrotransposons and their hosts. Cytogenet. Genome Res. 110: 70-90.
26. Lewinski, M.K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., et al. 2006. Retroviral DNA integration: Viral and cellular determinants of target-site selection. PLoS Pathog. 2: e60. doi: 10.1371/journal.ppat.0020060.
27. Li, L., Olvera, J.M., Yoder, K.E., Mitchell, R.S., Butler, S.L., Lieber, M., Martin, S.L., and Bushman, F.D. 2001. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20: 3272-3281.
28. Li, M., Mizuuchi, M., Burke, T.R., and Craigie, R. 2006. Retroviral DNA integration: Reaction pathway and critical intermediates. EMBO J. 25: 1295-1304.
29. Llano, M., Delgado, S., Vanegas, M., and Poeschla, E.M. 2004a. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 279: 55570-55577.
30. Llano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., and Poeschla, E.M. 2004b. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 78: 9524-9537.
31. Llano, M., Saenz, D.T., Meehan, A., Wongthida, P., Peretz, M., Walker, W.H., Teo, W., and Poeschla, E.M. 2006a. An essential role for LEDGF/p75 in HIV integration. Science 314: 461-464.
32. Llano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S., and Poeschla, E.M. 2006b. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. J. Mol. Biol. 360: 760-773.
33. Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., and Engelborghs, Y. 2003. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 278: 33528-33539.
34. Maertens, G.N., Cherepanov, P., and Engelman, A. 2006. Transcriptional co-activator p75 binds and tethers the c-Myc-interacting protein JPO2 to chromatin. J. Cell Sci. 119: 2563-2571.
35. Miller, D.G., Petek, L.M., and Russell, D.W. 2004. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet. 36: 767-773.
36. Mitchell, R.S., Beitzel, B.F., Schroder, A.R., Shinn, P., Chen, H., Berry, C.C., Ecker, J.R., and Bushman, F.D. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2: e234. doi: 10.1371/journal.pbio.0020234.
37. Mulder, L.C. and Muesing, M.A. 2000. Degradation of HIV-1 integrase by the N-end rule pathway. J. Biol. Chem. 275: 29749-29753.
38. Narezkina, A., Taganov, K.D., Litwin, S., Stoyanova, R., Hayashi, J., Seeger, C., Skalka, A.M., and Katz, R.A. 2004. Genome-wide analyses of avian sarcoma virus integration sites. J. Virol. 78: 11656-11663.
39. Nishizawa, Y., Usukura, J., Singh, D.P., Chylack, L.T., and Shinohara, T. 2001. Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleus. Cell Tissue Res. 305: 107-114.
40. Nowrouzi, A., Dittrich, M., Klanke, C., Heinkelein, M., Rammling, M., Dandekar, T., von Kalle, C., and Rethwilm, A. 2006. Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87: 1339-1347.
41. Sauer, B. 1998. Inducible gene targeting in mice using the Cre/lox system. Methods 14: 381-392.
42. Saunders, A., Core, L.J., and Lis, J.T. 2006. Breaking barriers to transcription elongation. Nat. Rev. Mol. Cell Biol. 7: 557-567.
43. Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R., and Bushman, F. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
44. Schwartz, O., Marechal, V., Friguet, B., Arenzana-Seisdedos, F., and Heard, J.-M. 1998. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72: 3845-3850.
45. Shinohara, T., Singh, D.P., and Fatma, N. 2002. LEDGF, a survival factor, activates stress-related genes. Prog. Retin. Eye Res. 21: 341-358.
46. Shun, M.-C., Daigle, J.E., Vandegraaff, N., and Engelman, A. 2007. Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein. J. Virol. 81: 166-172.
47. Silver, D.P. and Livingston, D.M. 2001. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol. Cell 8: 233-243.
48. Siva, A.C. and Bushman, F. 2002. Poly(ADP-ribose) polymerase 1 is not strictly required for infection of murine cells by retroviruses. J. Virol. 76: 11904-11910.
49. Sutherland, H.G., Newton, K., Brownstein, D.G., Holmes, M.C., Kress, C., Semple, C.A., and Bickmore, W.A. 2006. Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations. Mol. Cell. Biol. 26: 7201-7210.
50. Trobridge, G.D., Miller, D.G., Jacobs, M.A., Allen, J.M., Kiem, H.-P., Kaul, R., and Russell, D.W. 2006. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. 103: 1498-1503.
51. Turlure, F., Devroe, E., Silver, P.A., and Engelman, A. 2004. Human cell proteins and human immunodeficiency virus DNA integration. Front. Biosci. 9: 3187-3208.
52. Turlure, F., Maertens, G., Rahman, S., Cherepanov, P., and Engelman, A. 2006. A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res. 34: 1663-1675.
53. Vandegraaff, N. and Engelman, A. 2007. Molecular mechanism of HIV integration and therapeutic intervention. Expert Rev. Mol. Med. 9: 1-19.
54. Vandegraaff, N., Kumar, R., Hocking, H., Burke, T.R., Mills, J., Rhodes, D., Burrell, C.J., and Li, P. 2001. Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Antimicrob. Agents Chemother. 45: 2510-2516.
55. Vandegraaff, N., Devroe, E., Turlure, F., Silver, P.A., and Engelman, A. 2006. Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology 346: 415-426.
56. Vandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M., and Debyser, Z. 2006. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 80: 1886-1896.
57. Vanegas, M., Llano, M., Delgado, S., Thompson, D., Peretz, M., and Poeschla, E. 2005. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J. Cell Sci. 118: 1733-1743.
58. Wu, X., Li, Y., Crise, B., and Burgess, S.M. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
59. Xie, W., Gai, X., Zhu, Y., Zappulla, D.C., Sternglanz, R., and Voytas, D.F. 2001. Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p. Mol. Cell. Biol. 21: 6606-6614.
60. Zielske, S.P. and Stevenson, M. 2006. Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J. Virol. 80: 7275-7280.